ロード中...
Delivery systems of CRISPR/Cas9-based cancer gene therapy
CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats) is today one of the most reliable method for gene-editing, supporting previous gene therapies technologies such as TALEN, Meganucleases and ZFNs. There is a growing up number of manuscripts reporting several successful gene-edit...
保存先:
| 出版年: | J Biol Eng |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299643/ https://ncbi.nlm.nih.gov/pubmed/30574185 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13036-018-0127-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|